LabCorp 2013 Annual Report Download - page 7

3
multiple components of population health
management, providing primary care physicians
complete access to their patients’ healthcare
pictures, rules for monitoring gaps in care and
reporting that addresses more than 600 quality
measures. LabCorp Beacon: Analytics is part of
the comprehensive LabCorp Beacon platform
that helps providers reduce costs, improve
outcomes and enhance patient satisfaction.
Third Pillar:
Continue to improve effi ciency to off er the
most compelling value in laboratory services.
To maintain our position as the most effi cient
provider, we regularly evaluate our processes,
platforms, technologies, robotics, LEAN strategies
and rationalization programs. The successful
deployment of our Propel™ robot at our Powell
Center for Esoteric Testing in Burlington, North
Carolina, is an example of how we use technology
and innovation to improve performance. Propel
now splits and sorts most of the testing volume
in our Atlantic division, automating specimen
processing, increasing throughput and accuracy,
and reducing turnaround time.
In 2013, we opened a state-of-the art,
147,000-square-foot facility in Phoenix, Arizona,
to consolidate a number of our facilities located
in the Western United States. We continue to
evaluate all opportunities to improve effi ciency
through disciplined management and control
of expenses.
Fourth Pillar:
Scientifi c innovation at appropriate pricing.
We continue to be on the cutting edge of scientifi c
innovation: in 2013 alone, we introduced 152
new tests and enhanced our menu across several
testing disciplines.
I want to highlight BRCAssureSM, a suite of tests
that identify patients with BRCA mutations who
are at increased risk for breast, ovarian and other
cancers. The majority of individuals with hereditary
breast and ovarian cancer syndrome, as well as a
signifi cant percentage of those diagnosed with
breast cancers, exhibit mutations of the BRCA1
and BRCA2 genes, and LabCorp’s BRCA test menu
includes a comprehensive panel of BRCA1/2
complete gene sequence analysis and deletion/
duplication testing. Once a mutation is identifi ed,
family members can be tested for the known
mutations using the BRCAssure BRCA1 or BRCAssure
BRCA2 Targeted Analysis tests. Through this
expansion in our test menu, we continue to show
our commitment to Women’s Health testing and
personalized medicine.
What we believe diff erentiates LabCorp's BRCA
off ering from our competitors’ is our comprehensive
suite of services to assist doctors and patients in
ordering the test, assessing insurance coverage and
understanding the results. Our Care Coordination
preauthorization service assists patients who request
the test in understanding their insurance coverage
and fi nancial responsibility. Our 123 board-certifi ed
genetic counselors – which we believe is the
world’s largest complement of these highly skilled
professionals – help doctors and patients analyze,
assess and interpret the test results. This is a concrete
example of how we are implementing our mission
to be a trusted knowledge partner to multiple
healthcare stakeholders.
In addition to our commitment to Women’s Health,
we continue to enhance our test menu in other
important areas, particularly cancer diagnostics.
Our next-generation sequencing (NGS) multi-gene
oncology panel, IntelliGENSM, provides an assess-
ment of targetable mutations within a panel profi le
of 50 cancer genes known to be involved in the
development, progression and treatment of
cancers – including lung, colon and liver tumors.
With our NGS capabilities, LabCorp continues to
lead the industry in developing highly sensitive and
cost-eff ective ways of providing diagnostically
signifi cant information.
Fifth Pillar:
Develop knowledge services.
As demonstrated above, our mission to be a
knowledge partner to all healthcare stakeholders
cuts across each pillar of our strategy. Within the
fi fth pillar specifi cally, BeaconLBS® addresses a
growing need for guidance in ordering tests and
optimization of laboratory utilization. A wholly
owned LabCorp subsidiary, BeaconLBS brings
together the central roles of the laboratory, the
healthcare provider and the health plan to deliver
high-quality, effi cient and aff ordable laboratory
services for improved patient care. Its decision
support capabilities are designed to help physicians
select the appropriate test, test application and